mdt
-
Financial
Medtronic spends $585M to buy two companies
Medtronic Inc. said Thursday it spent $585 million to buy two companies in which it had already invested. Fridley-based Medtronic…
Read More » -
Medtronic deals with questions of biased research
In a strong course of action, The Spine Journal recently dedicated its entire June issue to a review of recombinant…
Read More » -
Spine
Infuse Furor May Force Medtronic Spine Business Sale. Who Would Buy?
A Wall Street analyst is speculating that Medtronic‘s (NYSE:MDT ) woes over its blockbuster Infuse product might lead the medical device company…
Read More » -
Biologics
Spine Experts Repudiate Medtronic Studies
In an extraordinary move, a group of spine specialists are publicly repudiating the research of other experts that has backed…
Read More » -
Biologics
Medtronic’s Infuse Off-Label, Doctor Payment Woes; Senate Probe
Medtronic is in trouble regarding its Infuse spine surgery product which was approved by the FDA in 2009 but has…
Read More » -
Spine
U.S. Senate panel probes Medtronic
A U.S. Senate committee has launched an investigation into reports that doctors with financial ties to the medical device company…
Read More » -
Spine
Official Senate Letter to Medtronic
http://media.jsonline.com/documents/Medtronic_Infuse_6_21_2011.pdf June 21, 2011Via Electronic TransmissionOmar Ishrak, Ph.D.Chairman and Chief Executive OfficerMedtronic, Inc.710 Medtronic ParkwayMinneapolis, MN 55432Dear Dr. Ishrak:The United…
Read More » -
Medtronic spokesman: State report in error, company has already completed local layoffs
Medtronic Inc. has already completed its reduction in force, according to a company spokesman, and will not lay off any…
Read More » -
Medtronic Reports Fourth Quarter Earnings
MINNEAPOLIS – May 24, 2011 – Medtronic, Inc. (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year…
Read More » -
Medtronic’s Edge in Spinal Treatment
By: Zacks Equity Research May 16, 2011 | Comments: 0 Recommended this article (2) MDT | ZMH | JNJ Print Share Leading medical…
Read More » -
Spine
Medtronic Still Working On CEO Search; Hawkins Stays On
By Jon Kamp, Of DOW JONES NEWSWIRES Medtronic Inc.’s (MDT) outgoing Chief Executive Bill Hawkins told employees Monday that the medical-device giant…
Read More » -
Spine
NYT: Medtronic spinal product faces widening probe
Medtronic Inc. products used to help bone growth in spinal-fusion procedures are facing growing scrutiny by both the FDA and…
Read More » -
Uncategorized
Judge nixes Medtronic, NuVasive motions in patent infringement case
A federal judge in California dealt blows to both sides in a patent infringement dispute over spinal implant technology between…
Read More » -
Kyphon® Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients
Medtronic of Canada Ltd. today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with non-surgical…
Read More » -
Spine
No OK for Medtronic spine product
By WENDY LEE, Star Tribune Last update: March 10, 2011 – 9:07 PM 1 Comment + Add comment Print this story E-mail…
Read More »